Australia's largest stock trading and investment forum Australia's #1 stock forum

RAC

Click for more information

0.58%

$1.74 race oncology ltd

Ann: December 2022 Preclinical & Clinical Programs Update, page-11

First 11 Last

Share
Profile

Follow
Boffin99

2,694 Posts.

2821

24/12/22

13:58

Post #: 65440466
Share

Originally posted by BillyHill: ↑

Other - Preclinical programs are underway exploring the potential utility of Zantrene as an anti- cancer agent across more than 100 cancer types. Early data from these programs suggests Zantrene may have broad utility across a wide range of cancer types.

The above was of interest and raises some questions…. Does RAC have the capacity to do this wide ranging preclinical study internally, or is it more likely being undertaken by parties external to RAC? Which parties would be undertaking this? Local or International? Pharma/Corporate or Academic Research? 100 is a
lot of different cancer types, will these include any brain cancers and paediatric cancers? Will the results form part of another important/high profile scientific paper? What kind of impact could this have for future cancer patients/potential market/of Zantreme?

Expand

I would note it specifies “cancer types” and not merely “sub types”, if correct we will get to understand the breadth of Zantrene’s super powers.

This will help convey value to Pharma and the market. I understand as a general rule of thumb most drugs work on single indication / targets. So if we improve on this things will be looking good!

RAC Price at posting: $2.02 Sentiment: Buy Disclosure: Held
19 Upvote

1 Great analysis

Reply

Top Stories

Pilot Energy awarded $6.5M in govt funding for Mid West Clean Energy Project

ARU

Arafura updates on total US$1B funding as export banks and lenders take notice; heading toward FID for Nolans

ITM

iTech Minerals flags high-grade rockchip finds, boasting one sample at +18% copper. What lies underground remains to be seen

DTM

Dart on-target for high-grade structures and multiple reefs at VIC's Rushworth

M4M

Macro Metals picks up 80% in Firebird's manganese plays; mining services operations to launch if decision to mine passed

There are more pages in this discussion • 2 more messages in this thread...

First 11 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.74		Change 0.010(0.58%)		Mkt cap ! $295.5M

Open	High	Low	Value	Volume
$1.76	$1.77	$1.60	$400.7K	236.4K

Buyers (Bids)

No.	Vol.	Price($)
1	550	$1.67

Sellers (Offers)

Price($)	Vol.	No.
$1.75	400	1

View Market Depth

No.	Vol.	Price($)
1	550	1.670
1	1000	1.660
1	8000	1.650
1	3000	1.640
1	2450	1.630

Price($)	Vol.	No.
1.750	400	1
1.755	990	1
1.770	3500	1
1.820	1030	2
1.835	12000	1

Last trade - 16.10pm 23/07/2024 (20 minute delay)

RAC (ASX) Chart

SPONSORED BY